ClinicalTrials.Veeva

Menu

Preventive Therapy of White Spot Lesions Using Different Remineralizing Agents in Children From 3 to 12 Years Old

U

Universitat Internacional de Catalunya

Status

Completed

Conditions

White Spot Lesion

Treatments

Other: FLUORINE VARNISH

Study type

Interventional

Funder types

Other

Identifiers

NCT04705428
UIC-ODP-WHITE SPOT

Details and patient eligibility

About

Compare by clinical observation, photographs and fluorescence the efficacy of sodium fluoride, silanofluoride and thiefenfluoride in treating white spots.

Full description

This in vivo study will be a randomized experimental clinical trial to be carried out in the Department of Pediatric Dentistry of the International University of Catalonia. Patients between the ages of 3 and 12, who attend the dental university clinic of the International University of Catalonia, will be part of the study.

Parents or legal guardians will be informed of the treatment procedure with a patient information sheet and informed consent will be given. Once signed, the patient will be assigned to one of the 3 study groups.

Accepting an alpha risk of 5% and with a power of 80% in a bilateral contrast, 15 subjects in each group are required to detect a minimum difference of 4 points between two groups, assuming that there are 3 groups and a standard deviation of 4.9. a follow- up loss rate of 10% has been estimated. The total number of children will be 45 by 15 for each group.

In order to analyze the degree of agreement of one examiner, 15 children will be evaluated twice, with a separation of one month.

Enrollment

75 patients

Sex

All

Ages

3 to 12 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Patients born between 2008 and 2017 of both sexes
  • Patients with the active white spot lesions on vesicular and buccal surfaces of the incisors and molars of different sizes and with or without sensitivity to external stimuli
  • Patients with white spot lesions that correspond to codifications of 0 to 2 of the ICDAS criteria.

Exclusion criteria

  • Patients with mental disabilities or systemic diseases
  • Patients with previously restored teeth
  • Patients with clinical symptoms of irreversible pulpitis, allergy to fluoride and copper

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

75 participants in 3 patient groups

Group I: intervention group 1
Experimental group
Description:
Professional hygiene will be carried out with the application of fluoride varnish (Duraphat) and the use of fluoride paste according to the age will be recommended for oral hygiene at home.
Treatment:
Other: FLUORINE VARNISH
Group II: intervention group 2
Experimental group
Description:
Professional hygiene will be carried out with the application of fluorine varnish (Tiefenfluoride) and the use of fluoride paste according to the age will be recommended for oral hygiene at home.
Treatment:
Other: FLUORINE VARNISH
Group III: intervention group 3
Experimental group
Description:
Professional hygiene will be carried out with the application of fluorine varnish (Fluor Protector S) and the use of fluoride paste according to the age will be recommended for oral hygiene at home.
Treatment:
Other: FLUORINE VARNISH

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems